Showing results (1131-1140 of 2,904) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|September 18, 2004
Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancerTie-gang Liu, James Q Yin, Bo-yang Shang, et al.Cancer Gene Therapy|September 18, 2004
Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathwaysAndrea L Volk, Angel A Rivera, Grier P Page, et al.Cancer Gene Therapy|May 1, 2004
Inhibition of B16BL6 tumor progression by coadministration of recombinant angiostatin K1-3 and endostatin genes with cationic liposomesKeun Sik Kim, Hong Sung Kim, Jin Seu Park, et al.Cancer Gene Therapy|July 10, 2004
Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell linesPamela M J McLaughlin, Monika Trzpis, Bart-Jan Kroesen, et al.Cancer Gene Therapy|December 14, 2004
Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitorPanfeng Fu, Junxia Chen, Yuxiang Tian, et al.Cancer Gene Therapy|December 4, 2004
Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytesByeong-Ho Park, Jin-Hwa Lee, Jin-Sook Jeong, et al.Cancer Gene Therapy|April 9, 2005
Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicinOlga Greco, Tanya M Powell, Brian Marples, et al.Cancer Gene Therapy|March 5, 2005
Development of an inducible suicide gene system based on human caspase 8Françoise Carlotti, Arnaud Zaldumbide, Patrick Martin, et al.Cancer Gene Therapy|February 19, 2005
RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesisRiccardo Taulli, Paolo Accornero, Antonia Follenzi, et al.Pageof 291